- Home
- AGI vs PEN Comparison
AGI vs PEN Comparison
Compare AGI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGI
- PEN
- Stock Information
- Founded
- AGI 1993
- PEN 2004
- Country
- AGI Philippines
- PEN United States
- Employees
- AGI N/A
- PEN N/A
- Industry
- AGI Precious Metals
- PEN Medical/Dental Instruments
- Sector
- AGI Basic Materials
- PEN Health Care
- Exchange
- AGI Nasdaq
- PEN Nasdaq
- Market Cap
- AGI 11.2B
- PEN 9.0B
- IPO Year
- AGI 1999
- PEN 2015
- Fundamental
- Price
- AGI $24.84
- PEN $242.93
- Analyst Decision
- AGI Buy
- PEN Strong Buy
- Analyst Count
- AGI 4
- PEN 16
- Target Price
- AGI $30.38
- PEN $300.47
- AVG Volume (30 Days)
- AGI 3.6M
- PEN 531.0K
- Earning Date
- AGI 07-30-2025
- PEN 07-29-2025
- Dividend Yield
- AGI 0.01%
- PEN N/A
- EPS Growth
- AGI 57.62
- PEN 915.21
- EPS
- AGI 0.82
- PEN 3.74
- Revenue
- AGI $1,507,900,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- AGI N/A
- PEN $14.60
- Revenue Next Year
- AGI $17.45
- PEN $14.24
- P/E Ratio
- AGI $30.45
- PEN $64.87
- Revenue Growth
- AGI 29.86
- PEN 12.92
- 52 Week Low
- AGI $15.74
- PEN $160.18
- 52 Week High
- AGI $31.00
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- AGI 41.93
- PEN 50.26
- Support Level
- AGI $23.92
- PEN $225.48
- Resistance Level
- AGI $26.19
- PEN $261.81
- Average True Range (ATR)
- AGI 0.79
- PEN 6.51
- MACD
- AGI -0.13
- PEN 2.63
- Stochastic Oscillator
- AGI 32.62
- PEN 48.03
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.